Matthew Scholz

Active Investor

Founder and Chief Executive Officer at Oisín Biotechnologies at Oisin BioTechnologies

Seattle, Washington

Matthew Scholz, Founder and Chief Executive Officer at Oisín Biotechnologies at Oisin BioTechnologies is an active investor based in Seattle, Washington. This profile covers what Matthew Scholz backs, at which stage, and how founders can reach out in 2026.

Investor type: Angel
Stages: Pre SeedSeed
Invests in: Healthcare & BiotechBiotech & PharmaSaaS & EnterpriseIoT & Connected DevicesGaming & EntertainmentMedia & Content
Location: Seattle, Washington
Typical check: $150K
Past investments: 6

Notable investments

Immusoft CorporationImmusoftOisin BioTechnologiesPoint B TelematicsHiveBio Community LabSigma Genetics, Inc

How to reach Matthew Scholz

Angels and operators like Matthew Scholz reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Matthew Scholz invest in?

Matthew Scholz invests in Healthcare & Biotech, Biotech & Pharma, SaaS & Enterprise and IoT & Connected Devices, typically at Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.